Micillic Lda

Micillic is a research-focused company specializing in nanotechnology and probiotic technology aimed at neurodegenerative disease treatment. The firm develops innovative formulations, including proprietary probiotic strains and CereQ10 technology, which are designed to influence brain health through the gut-brain axis. By leveraging nano-micelle technology, the company provides expert formulation services that encompass product development, optimization, manufacturing, and quality control.

These research efforts are directed toward addressing complex neurological conditions, such as Alzheimer's and Parkinson's diseases, by targeting gut health. Beyond its scientific research, Micillic functions as a partner for businesses and researchers, offering customized formulation services to bring health and nutritional products from concept to commercialization. The company operates as a privately held entity, maintaining its research initiatives alongside its commercial services for clients in the health, longevity, and nutrition science sectors.